Prevenar
Showing 1 - 25 of 167
Sepsis Trial in Nice (Blood sample taken)
Recruiting
- Sepsis
- Blood sample taken
-
Nice, Provence Alpes Cote d'Azur, FranceUniversity Hospital of Nice
Jan 23, 2023
Pneumococcal Infections Trial in Adelaide (Gamma-PN3, Pneumovax-23, Prevenar-13)
Recruiting
- Pneumococcal Infections
- Gamma-PN3
- +3 more
-
Adelaide, South Australia, AustraliaUniversity of Adelaide
Aug 1, 2023
A Safety Study For Prevenar 13 Among Chinese Children
Completed
- Seizures
- +3 more
-
Shanghai, ChinaSchool of Public Health at Fudan University
Jul 30, 2021
Pneumococcal Infections Trial in Adelaide (Gamma-PN3, Prevenar-13, Pneumovax-23)
Recruiting
- Pneumococcal Infections
- Gamma-PN3
- +3 more
-
Adelaide, South Australia, AustraliaCMAX
Dec 29, 2022
Infections, Streptococcal, Streptococcus Pneumoniae Vaccines Trial in Cuernavaca, Monterrey, Mexico (Synflorix (3-Dose),
Completed
- Infections, Streptococcal
- Streptococcus Pneumoniae Vaccines
- Synflorix (3-Dose)
- +4 more
-
Cuernavaca, Morelos, Mexico
- +2 more
Feb 8, 2021
Herpes Zoster Trial in Worldwide (HZ/su vaccine GSK1437173A, Prevenar13)
Completed
- Herpes Zoster
- HZ/su vaccine GSK1437173A
- Prevenar13
-
Marlborough, Massachusetts
- +12 more
Dec 23, 2021
Dengue, Dengue Hemorrhagic Fever Trial in Mexico (Live, attenuated, recombinant dengue serotype 1, 2, 3, and 4 virus, DTaP
Completed
- Dengue
- Dengue Hemorrhagic Fever
- Live, attenuated, recombinant dengue serotype 1, 2, 3, and 4 virus
- +4 more
-
Acapulco, Guerrero, Mexico
- +3 more
Mar 15, 2022
Splenectomised Patients Trial in Paris (Prevenar13 (PCV13) and Pneumovax (PPS23), Placebo / Pneumovax (PPS23), Blood sample)
Active, not recruiting
- Splenectomised Patients
- Prevenar13 (PCV13) and Pneumovax (PPS23)
- +2 more
-
Paris, FranceCIC 1417 Cochin-Pasteur - GH Broca-Cochin-Hôtel-Dieu
Oct 10, 2022
CLL, Vaccine Response Trial in Örebro (PCV13, PPSV23)
Active, not recruiting
- CLL
- Vaccine Response
- PCV13
- PPSV23
-
Örebro, SwedenMagdalena Kättström
Mar 29, 2022
Pneumococcal Disease Trial (20-valent pneumococcal conjugate vaccine, 13-valent pneumococcal conjugate vaccine)
Recruiting
- Pneumococcal Disease
- 20-valent pneumococcal conjugate vaccine
- 13-valent pneumococcal conjugate vaccine
-
Budapest, Hungary
- +33 more
Jan 11, 2023
Invasive Pneumococcal Disease Trial in Hringbraut, Reykjavik (13-valent pneumococcal conjugate vaccine (13vPnC), Blood draw)
Completed
- Invasive Pneumococcal Disease
- 13-valent pneumococcal conjugate vaccine (13vPnC)
- Blood draw
-
Hringbraut, Reykjavik, Iceland
- +1 more
Oct 14, 2021
Streptococcus Pneumoniae Infection Trial in China (13-valent pneumococcal conjugate vaccine (multivalent conjugate), Prevenar
Recruiting
- Streptococcus Pneumoniae Infection
- 13-valent pneumococcal conjugate vaccine (multivalent conjugate)
- Prevenar 13
-
Hechi City, Guangxi Zhuang Autonomous Region, China
- +4 more
Feb 26, 2023
Invasive Pneumococcal Infection Trial in Paris (PCV13, PPV23, Rituximab)
Completed
- Invasive Pneumococcal Infection
- PCV13
- +2 more
-
Paris, FrancePôle de Médecine Interne, Centre de référence " Maladies systémi
Jun 7, 2022
Pneumococcal Disease Trial in Seoul (EuPCV15, Prevenar13)
Completed
- Pneumococcal Disease
- EuPCV15
- Prevenar13
-
Seoul, Korea, Republic ofThe Catholic University of Seoul St.Mary's Hospital
Oct 6, 2021
Streptococcus Pneumonia Trial (PPV23, PCV13, Saline for injection)
Not yet recruiting
- Streptococcus Pneumonia
- PPV23
- +2 more
- (no location specified)
Jul 21, 2021
Pneumococcal Infection Trial (Pneumo 23® 0,5, Pneumo 23® 0,1, Prevenar13® 0,5)
Completed
- Pneumococcal Infection
- Pneumo 23® 0,5
- +2 more
- (no location specified)
Jul 31, 2021
Sepsis Trial in United Kingdom (Prevenar 13, Sodium Chloride 0.9%)
Active, not recruiting
- Sepsis
- Prevenar 13
- Sodium Chloride 0.9%
-
Belfast, United Kingdom
- +11 more
Dec 12, 2022
Rheumatoid Arthritis Trial in France, Monaco (pneumococcal polysaccharide vaccine, pneumococcal conjugate vaccine, Abatacept)
Completed
- Rheumatoid Arthritis
- pneumococcal polysaccharide vaccine
- +2 more
-
Montpellier, Hérault, France
- +10 more
Dec 30, 2021
Pneumococcal Vaccines Trial in Ho Chi Minh City (PCV10, PCV13)
Active, not recruiting
- Pneumococcal Vaccines
- PCV10
- PCV13
-
Ho Chi Minh City, VietnamPasteur Institute of Ho Chi Minh City
May 20, 2021
Infectious Diseases Trial in Oxford (DTaP/IPV/Hib vaccine, 13 valent Pneumococcal Conjugate Vaccine, Rotavirus vaccine)
Completed
- Infectious Diseases
- DTaP/IPV/Hib vaccine
- +5 more
-
Oxford, Oxfordshire, United KingdomCentre for Clinical Vaccinology and Tropical Medicine
Sep 17, 2021
Infections, Streptococcal, Streptococcus Pneumoniae Trial in Germany (Pneumococcal conjugate vaccine GSK 1024850A, Pneumococcal
Completed
- Infections, Streptococcal
- Streptococcus Pneumoniae
- Pneumococcal conjugate vaccine GSK 1024850A
- Pneumococcal conjugate vaccine Prevenar™ (Wyeth Lederle's)
-
Mannheim, Baden-Wuerttemberg, Germany
- +16 more
Nov 4, 2020
Diphtheria Trial in Schoenau Am Koenigssee, Milano, Santiago de Compostela (DTPa-HBV-IPV/Hib, DTaP5-HBV-IPV-Hib, Pneumococcal
Completed
- Diphtheria
- DTPa-HBV-IPV/Hib
- +2 more
-
Rosenheim, Bayern, Germany
- +19 more
Jan 24, 2023
Hiv, Meningococcal Infections, Pneumococcal Infections Trial in Hvidovre (Neisseria meningitidis oligosaccharide conjugate
Recruiting
- Hiv
- +2 more
- Neisseria meningitidis oligosaccharide conjugate vaccine and recombinant protein-based vaccine
- 13 valent pneumococcal conjugate vaccine and 23 valent pneumococcal polysaccharide vaccine
-
Hvidovre, DenmarkHvidovre Hospital
May 5, 2021
Infections, Meningococcal Trial in Worldwide (Meningococcal vaccine GSK134612, Prevenar 13™)
Completed
- Infections, Meningococcal
- Meningococcal vaccine GSK134612
- Prevenar 13™
-
Garran, Australian Capital Territory, Australia
- +50 more
Sep 7, 2021